Safety and Hemostatic Effectiveness of SURGICEL® Powder in Mild and Moderate Intraoperative Bleeding.

MLA

Al-Attar, Nawwar, et al. “Safety and Hemostatic Effectiveness of SURGICEL® Powder in Mild and Moderate Intraoperative Bleeding.” Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, vol. 29, Jan. 2023, p. 10760296231190376. EBSCOhost, https://doi.org/10.1177/10760296231190376.

APA

Al-Attar, N., de Jonge, E., Kocharian, R., Ilie, B., Barnett, E., & Berrevoet, F. (2023). Safety and Hemostatic Effectiveness of SURGICEL® Powder in Mild and Moderate Intraoperative Bleeding. Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 29, 10760296231190376. https://doi.org/10.1177/10760296231190376

Chicago

Al-Attar, Nawwar, Eric de Jonge, Richard Kocharian, Bogdan Ilie, Ellie Barnett, and Frederik Berrevoet. 2023. “Safety and Hemostatic Effectiveness of SURGICEL® Powder in Mild and Moderate Intraoperative Bleeding.” Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 29 (January): 10760296231190376. doi:10.1177/10760296231190376.